Expression of survivin and caspase 3 in oral squamous cell carcinoma and peritumoral tissue

Asian Pacific Journal of Cancer Prevention

Volumn 13, Issue 10, 2012, Pages 5027-5031

  Li, S X ^a,b   Chai, L ^b,d   Cai, Z G ^c   Jin, L J ^b   Chen, Y ^c   Wu, H R ^a   Sun, Z ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c PEKING UNIVERSITY SCHOOL AND HOSPITAL OF STOMATOLOGY   (China)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Apoptosis; Caspase 3; Oral squamous cell carcinoma; Survivin

Indexed keywords

EID: 84874003287     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2012.13.10.5027     Document Type: Article

References (29)

1. Blanc C, Deveraux QL, Krajewski S, et al (2000). Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells. Cancer Res, 60, 4386-90.
2. Bursch W, Karwan A, Mayer M, et al (2008). Cell death and autophagy: cytokines, drugs, and nutritional factors. Toxicology, 254, 147-57.
3. De Maria S, Pannone G, Bufo P, et al (2009). Survivin gene-expression and splicing isoforms in oral squamous cell carcinoma. J Cancer Res Clin Oncol, 135, 107-16.
4. Fraunholz I, Rödel C, Distel L, et al (2012). High survivin expression as a risk factor in patients with anal carcinoma treated with concurrent chemoradiotherapy. Radiat Oncol, 7, 88.
5. Gibson S, Shillitoe EJ(2006). Analysis of apoptosis-associated genes and pathways in oral cancer cells. J Oral Pathol Med, 35, 146-54.
6. Gomes TS, Oshima CT, Segreto HR, et al (2011). The extrinsic apoptotic signaling pathway in gastric adenocarcinomas assessed by tissue microarray. Pathol Res Pract, 207, 613-7.
7. Grutter MG (2000). Caspases: key players in programmed cell death. Curr Opin Struct Biol, 10, 649-55.
8. Halasova E, Adamkov M, Matakova T, et al (2012). Expression of Ki-67, Bcl-2, Survivin and p53 Proteins in Patients with Pulmonary Carcinoma. Adv Exp Med Biol, 756, 15-21.
9. Kanwar JR, Kamalapuram SK, Kanwar RK (2012). Survivin Signaling in Clinical Oncology: A Multifaceted Dragon. Med Res Rev. doi: 10.1002/med.21264.
10. Khan Z, Tiwari RP, Mulherkar R, et al (2009). Detection of survivin and p53 in human oral cancer: correlation with clinicopathologic findings. Head Neck, 31, 1039-48.
11. Kim WH, Yeo M, Kim MS, et al (2000). Role of caspase-3 in apoptosis of colon cancer cells induced by nonsteroidal anti-inflammatory drugs. Int J Colorectal Dis, 15, 105-11.
12. Ko SY, Dass CR, Nurgali K (2012). Netrin-1 in the developing enteric nervous system and colorectal cancer. Trends Mol Med, 18, 544-54.
13. Li J, Chen P, Li XQ, et al (2012). Elevated levels of survivin and livin mRNA in bronchial aspirates as markers to support the diagnosis of lung cancer. Int J Cancer. doi: 10.1002/ijc.27757.
14. Loncarević S, Vignjević S, Jović N, et al (2012). Significance of pathohistological findings and the expression of Bcl-2 in diagnosis and treatment of oral planocellular carcinoma. Vojnosanit Pregl, 69, 314-9.
15. Malaguarnera R, Morcavallo A, Belfiore A (2012). The insulin and igf-I pathway in endocrine glands carcinogenesis. J Oncol, 2012, 635614.
16. Mangiola A, Lama G, Giannitelli C, et al (2008). Stem cell marker nestin and c-Jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications. Clin Cancer Res, 13, 6970-7.
17. McKenzie JA, Grossman D (2012). Role of the apoptotic and mitotic regulator survivin in melanoma. Anticancer Res, 32, 397-404.
18. Preuss SF, Weinell A, Molitor M, et al (2008). Survivin and epidermal growth factor receptor expression in surgically treated oropharyngeal squamous cell carcinoma. Head Neck, 30, 1318-24.
19. Ryan BM, Konecny GE, Kahlert S, et al (2006). Survivin expression in breast cancer predicts clinical outcome and is associated with HER2, VEGF, urokinase plasminogen activator and PAI-1. Ann Oncol, 17, 597-604.
20. Seol JG, Park WH, Kim ES, et al (2001). Potential role of caspase-3 and -9 in arsenic trioxide-mediated apoptosis in PCI-1 head and neck cancer cells. Int J Oncol, 18, 249-55.
21. Sica G, Lama G, Anile C, et al (2011). Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma. Int J Oncol, 38, 41-9.
22. Span PN, Tjan-Heijnen VC, Manders P, et al (2006). High survivin predicts a poor response to endocrine therapy, but a good response to chemotherapy in advanced breast cancer. Breast Cancer Res Treat, 98, 223-30.
23. Suzuki A, Hayashida M, Ito T, et al (2000). Survivin initiates cell cycle entry by the competitive interaction with Cdk4/p16(INK4a) and Cdk2/cyclin E complex activation. Oncogene, 19, 3225-34.
24. Suzuki A, Ito T, Kawano H, et al (2000). Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene, 19, 1346-53.
25. Tamm I, Kornblau SM, Segall H, et al (2000). Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias. Clin Cancer Res, 6, 1796-803.
26. Waligórska-Stachura J, Jankowska A, Waśko R, et al (2012). Survivin-- prognostic tumor biomarker in human neoplasms--review. Ginekol Pol, 83, 537-40.
27. Yu JQ, Bao W, Lei JC (2012). Emodin regulates apoptotic pathway in human liver cancer cells. Phytother Res. doi: 10.1002/ptr.4703.
28. Zhang LQ, Wang J, Jiang F, et al (2012). Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis. PLoS One, 7, e34100.
29. Zheng WE, Chen H, Yuan SF, et al (2012). Overexpression of βIII-tubulin and survivin associated with drug resistance to docetaxel-based chemotherapy in advanced gastric cancer. J BUON, 17, 284-90.